In vivo quantification of quantum dot systemic transport in C57BL/6 hairless mice following skin application post-ultraviolet radiation.

Autor: Jatana S; Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA., Palmer BC; Department of Environmental Medicine, University of Rochester Medical Center, New York, USA., Phelan SJ; Department of Environmental Medicine, University of Rochester Medical Center, New York, USA., Gelein R; Department of Environmental Medicine, University of Rochester Medical Center, New York, USA., DeLouise LA; Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA. Lisa_DeLouise@urmc.rochester.edu.; Department of Dermatology, University of Rochester Medical Center, Dermatology and Biomedical Engineering, 601 Elmwood Avenue, Box 697, Rochester, NY, 14642, USA. Lisa_DeLouise@urmc.rochester.edu.
Jazyk: angličtina
Zdroj: Particle and fibre toxicology [Part Fibre Toxicol] 2017 Apr 14; Vol. 14 (1), pp. 12. Date of Electronic Publication: 2017 Apr 14.
DOI: 10.1186/s12989-017-0191-7
Abstrakt: Background: Previous work has demonstrated size, surface charge and skin barrier dependent penetration of nanoparticles into the viable layers of mouse skin. The goal of this work was to characterize the tissue distribution and mechanism of transport of nanoparticles beyond skin, with and without Ultraviolet Radiation (UVR) induced skin barrier disruption. Atomic absorption spectroscopy (AAS), flow cytometry and confocal microscopy were used to examine the effect of UVR dose (180 and 360 mJ/cm 2 UVB) on the skin penetration and systemic distribution of quantum dot (QD) nanoparticles topically applied at different time-points post UVR using a hairless C57BL/6 mouse model.
Results: Results indicate that QDs can penetrate mouse skin, regardless of UVR exposure, as evidenced by the increased cadmium in the local lymph nodes of all QD treated mice. The average % recovery for all treatment groups was 69.68% with ~66.84% of the applied dose recovered from the skin (both epicutaneous and intracutaneous). An average of 0.024% of the applied dose was recovered from the lymph nodes across various treatment groups. When QDs are applied 4 days post UV irradiation, at the peak of the skin barrier defect and LC migration to the local lymph node, there is an increased cellular presence of QD in the lymph node; however, AAS analysis of local lymph nodes display no difference in cadmium levels due to UVR treatment.
Conclusions: Our data suggests that Langerhans cells (LCs) can engulf QDs in skin, but transport to the lymph node may occur by both cellular (dendritic and macrophage) and non-cellular mechanisms. It is interesting that these specific nanoparticles were retained in skin similarly regardless of UVR barrier disruption, but the observed skin immune cell interaction with nanoparticles suggest a potential for immunomodulation, which we are currently examining in a murine model of skin allergy.
Databáze: MEDLINE
Externí odkaz: